Key Takeaways
- Leqembi, the first ever drug for treating the cause of Alzheimers has been approved by the FDA
- Even so, the makers of the drug Biogen and Eisai have both fallen on the announcement
- It follows guidance from Medicare and Medicaid in early June on how to access the drug, plus positive commentary from an advisory committee, suggesting that the value of the…
Read the full article here